![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 18, Issue 3, 1083-1097, March 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,,
*St. Michael's Hospital Research Institute, Toronto, ON, Canada M5B 1W8; Department of Surgery, University of Toronto, ON, Canada M5G 1L5; Nephrology Research Center, Semmelweis University, Budapest, Hungary H-1089; ||Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan 113-8421; ¶CIHR Group in Matrix Dynamics, University of Toronto, Toronto, ON, Canada M5S 3E2; and #First Department of Internal Medicine, Semmelweis University, Budapest, Hungary H-1083
Submitted July 17, 2006;
Revised December 15, 2006;
Accepted January 3, 2007
Monitoring Editor: Asma Nusrat
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
1 (TGF-1)-induced transdifferentiation of kidney tubular cells into 
-smooth muscle actin (SMA)–expressing myofibroblasts. Here we analyzed the underlying contact-dependent mechanisms. Ca2+ removal–induced disruption of intercellular junctions provoked Rho/Rho kinase (ROK)-mediated myosin light chain (MLC) phosphorylation and Rho/ROK-dependent SMA promoter activation. Importantly, myosin-based contractility itself played a causal role, because the myosin ATPase inhibitor blebbistatin or a nonphosphorylatable, dominant negative MLC (DN-MLC) abolished the contact disruption-triggered SMA promoter activation, eliminated the synergy between contact injury and TGF-1, and suppressed SMA expression. To explore the responsible mechanisms, we investigated the localization of the main SMA-inducing transcription factors, serum response factor (SRF), and its coactivator myocardin-related transcription factor (MRTF). Contact injury enhanced nuclear accumulation of SRF and MRTF. These processes were inhibited by DN-Rho or DN-MLC. TGF-1 strongly facilitated nuclear accumulation of MRTF in cells with reduced contacts but not in intact epithelia. DN-myocardin abrogated the Ca2+-removal– ± TGF-1–induced promoter activation. These studies define a new mechanism whereby cell contacts regulate epithelial-myofibroblast transition via Rho-ROK-phospho-MLC–dependent nuclear accumulation of MRTF. |
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
). Recently EMT has emerged as a central mechanism underlying tubulointerstitial fibrosis (TIF), a progressive pathology common to a variety of chronic kidney diseases (Strutz et al., 1995; Liu, 2004). In a transgenic mouse model of TIF, nearly 40% of fibroblasts have been shown to originate from the tubular epithelium that underwent EMT (Iwano et al., 2002). During this process tubular cells lose their polygonal shape and epithelial markers (e.g., E-cadherin), acquire fibroblast-specific proteins (e.g., FSP1), increasingly synthesize extracellular matrix (e.g., fibronectin), and ultimately differentiate into -smooth muscle actin (SMA)-positive myofibroblasts (for a review see Kalluri and Neilson, 2003). Myofibroblasts represent a highly contractile cell type that is thought to be critical for wound contraction, tissue repair, and the pathogenesis of fibrocontractive diseases (Gabbiani, 2003; Chaponnier and Gabbiani, 2004; Desmouliere et al., 2005).
Several laboratories including our own have established tubular cell models to study EMT and the development of myofibroblasts (Fan et al., 1999; Yang and Liu, 2001; Masszi et al., 2003). Both in vivo and in vitro, transforming growth factor-1 (TGF-1) is the main inducer of EMT and fibrogenesis (Bottinger and Bitzer, 2002). However, our previous studies revealed that in intact, confluent monolayers of tubular (LLC-PK1) cells, TGF-1 alone is insufficient to induce SMA synthesis and thus myofibroblast formation. The additional prerequisite is a partial loss or injury of intercellular contacts, which can be modeled by subconfluence, mechanical wounding or disassembly of adherens junctions (AJ) via Ca2+ removal (Masszi et al., 2004). These studies have defined a two-hit (TGF-1 and contact injury) model, in which intercellular junctions are not only targets but also active regulators of EMT. Indeed TGF-1 and contact disassembly exert strong synergy in the stimulation of the SMA promoter.
While searching for mechanisms responsible for the cell contact–dependent regulation of SMA expression, we have previously found that -catenin contributes to this phenomenon. -catenin, when liberated from the AJs upon contact injury and rescued from proteolysis in a TGF-1–dependent manner, exerts a potentiating effect on the activation of the SMA promoter. However, the SMA promoter does not harbor a -catenin–responsive cis-element, and overexpression of -catenin alone does not activate SMA expression, indicating that the effect is indirect and other contact-dependent factors must also be involved. These considerations prompted us to investigate the possible relationship between contact injury and the main direct regulators of the SMA promoter.
In muscle cells and fibroblasts, the expression of smooth muscle–specific genes, including SMA, is primarily controlled by serum response factor (SRF; Hill et al., 1995; Mack et al., 2000) and its recently discovered coactivators, myocardin and the myocardin-related transcription factors (MRTFs) also called MAL or MKL (Wang et al., 2001, 2002; Cen et al., 2003; Du et al., 2003; Selvaraj and Prywes, 2003). Rho GTPase–mediated actin cytoskeleton reorganization has been long recognized as a key activator of SRF (Sotiropoulos et al., 1999; Mack et al., 2001), but until recently the underlying mechanisms remained undefined. Novel studies suggest that SRF is activated by the Rho-dependent nuclear translocation of MRTF (Miralles et al., 2003; Du et al., 2004). According to the current view, in quiescent cells MRTF is associated with monomeric (G) actin and this complex cannot enter the nucleus. Stimulus-induced Rho activation causes enhanced incorporation of G-actin into actin filaments, which then leads to dissociation of MRTF followed by its nuclear translocation (Sotiropoulos et al., 1999; Miralles et al., 2003). Two Rho effector pathways have been implicated in the mediation of this effect: increased actin polymerization via formin proteins (Copeland and Treisman, 2002) and reduced F-actin severing by the LIM kinase-cofilin pathway (Geneste et al., 2002). Rho might also regulate the localization of SRF; however, this aspect is controversial and the underlying mechanisms are not known (Camoretti-Mercado et al., 2000; Liu et al., 2003a; Cen et al., 2004).
Importantly, contact injury also leads to characteristic changes in the cytoskeleton. Previous work by us and others has shown that disassembly of epithelial junctions leads to robust myosin light chain (MLC) phosphorylation (Frixione et al., 2001; Ivanov et al., 2004; Di Ciano-Oliveira et al., 2005), a process mediated by the downstream Rho effector, Rho kinase (ROK) (Szaszi et al., 2005). Epithelial wounding–induced MLC phosphorylation and acto-myosin ring formation is believed to be critical for wound closure (Darenfed and Mandato, 2005). This scenario then raises a number of intriguing questions about the potential connection between cell contacts and the regulation of SMA expression. Specifically we sought to determine whether contact disassembly impacts on the localization of MRTF and/or SRF in epithelial cells, and whether such an effect might be mediated by the Rho-ROK pathway. We also asked whether myosin phosphorylation per se is required for the contact-dependent regulation of the SMA promoter. Our results indicate that contact injury–induced Rho-ROK–mediated MLC phosphorylation regulates MRTF distribution, which in turn plays a central role in epithelial-myofibroblast transformation.
|
MATERIALS AND METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
-SMA, anti--actin, and anti-FLAG antibodies were purchased from Sigma (St. Louis, MO), anti-monophospho-MLC from Cell Signaling Technology (Danvers, MA), and anti-histones from Chemicon (Temecula, CA). The polyclonal anti-alpha-BSAC antibody raised against the mouse MKL1 protein was described previously (Sasazuki et al., 2002). FITC- and Cy3-labeled, as well as peroxidase-conjugated anti-mouse, anti-rabbit, and anti-goat secondary antibodies were obtained from Jackson ImmunoResearch Laboratories (West Grove, PA). DAPI used for nuclear staining was purchased from Invitrogen (Burlington, ON, Canada). Y-27632 and blebbistatin was from Calbiochem (La Jolla, CA), rhodamine-labeled phalloidin from Cytoskeleton (Denver, CO), and human recombinant TGF-1 from Sigma.
Cell Culture and Treatments
LLC-PK1 (CL4) proximal tubular cells were cultured in DMEM (Invitrogen) and Chinese hamster ovary (CHO) cells in -minimal essential medium (-MEM, Invitrogen), supplemented with 10% FBS (Invitrogen) and 1% penicillin/streptomycin at 37°C under humidified atmosphere of air/CO2 (19:1). Cells were grown on 6- or 12-well plates, on glass coverslips, or on 10-cm dishes to either 100% confluence or subconfluence as indicated in the legend of the corresponding figures, and then subjected to various treatments. For acute Ca2+ removal, cells were preincubated in an isotonic NaCl-based medium (140 mM NaCl, 3 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 5 mM glucose, 20 mM HEPES, pH 7.4) for 10 min, and then the medium was replaced with the same basic solution lacking CaCl2 and supplemented with 1 mM EGTA. For chronic Ca2+ deprivation, the cells were washed four times with phosphate-buffered saline (PBS, Invitrogen), and once with serum- and Ca2+-free DMEM followed by incubation in the latter solution. Control samples were incubated with serum-free DMEM containing Ca2+. Where applied, TGF-1 (10 ng/ml or vehicle for controls) was added to the cells for times specified at the individual experiments. For inhibitor studies, cells were preincubated with 10 µM Y-27632 or 50–100 µM blebbistatin for various times as described in the figure legends. Wounding of confluent monolayers grown on glass coverslips was achieved by scraping a 1–3-mm gap using a rubber policeman. Cells were fixed 6 h after wounding.
Plasmids
The PA3-Luc vector containing a 765-bp fragment of the rat SMA promoter (pSMA-Luc) was a kind gift from Dr. R. A. Nemenoff (Department of Medicine, University of Colorado), and was used as in our previous studies (Masszi et al., 2003). In certain experiments we used pGL3-SMA-Luc plasmid (provided by Dr. S. H. Phan, University of Michigan Medical School, Ann Arbor; Hu et al., 2003), which harbors the same promoter region inserted into pGL3 luciferase vector. As internal control for transfection efficiency, thymidine kinase–driven Renilla luciferase vector (pRL-TK, Promega, Madison, WI) was used. Plasmids (pcDNA3.1) encoding for the C-terminally His- and Myc-tagged wild-type (WT) myosin regulatory light chain-2 (WT-MLC) and its dominant negative version in which T18 and S19 were replaced with alanine (DN-MLC), were kind gifts from Dr. H. Hosoya (Department of Biological Sciences, Hiroshima University; Iwasaki et al., 2001; Di Ciano-Oliveira et al., 2005). FLAG-tagged MRTF-A, MRTF-B, and the dominant negative truncation mutant (
C585) of myocardin were kindly provided by Dr. E. N. Olson (Department of Molecular Biology, University of Texas), and were described previously (Wang et al., 2001). Vectors encoding for Myc-tagged constitutive active RhoA (Q63L, CA-Rho), dominant negative RhoA (T19N, DN-Rho), and GFP-p190RhoGAP were described and used in our previous studies (Masszi et al., 2003). The SBE4-Luc reporter plasmid, which contains four tandem repeats of the SMAD-binding element, was a kind gift of Dr. A. B. Roberts (National Institutes of Health, Bethesda; Felici et al., 2003).
Transient Transfection and Luciferase Promoter Activity Assays
If not otherwise stated, cells were grown on six-well plates and transfected at a 100% confluence using 2.5 µl FuGene6 (Roche, Laval, QC, Canada) reagent/1 µg DNA. For promoter activity measurements, cells were cotransfected with 0.5 µg pSMA-Luc (or pGL3-SMA-Luc), 0.05 µg pRL-TK, and 2 µg of either empty vector (pcDNA3.1) or the specific construct to be tested. After a 24-h incubation period, cells were washed and placed in a serum-free medium, either containing or lacking Ca2+. TGF-1 (10 ng/ml) or its vehicle was added to the cells after 4 h, and the incubation was continued for an additional 16 h. Cells were then lysed in 500 µl passive lysis buffer (Promega), and the samples were subjected to a cycle of freezing/thawing, and then clarified by centrifugation (12,000 rpm, 5 min at 4°C). Firefly and Renilla luciferase activities were measured by the Dual-Luciferase Reporter Assay Kit (Promega) using a Berthold Lumat LB 9507 luminometer (Bad Wildbad, Germany) according to the manufacturer's instructions. Results were normalized by dividing the Firefly luciferase activity with the Renilla luciferase activity of the same sample. For each condition duplicate or triplicate measurements were performed, and experiments were repeated at least three times. For immunofluorescence analysis typically 1–2 µg plasmid DNA was transfected per coverslip.
Rho Activity Assay
Rho activation was assessed by an affinity pulldown assay as in our previous studies (Di Ciano-Oliveira et al., 2003). Briefly, after the indicated treatment, cells grown in 10-cm dishes were lysed in 800 µl of ice-cold Rho lysis buffer (100 mM NaCl, 50 mM Tris-Base, pH 7.6, 20 mM NaF, 10 mM MgCl2, and 1% Triton X-100) supplemented with 0.5% deoxycholic acid, 0.1% SDS, 20 µl/ml protease inhibitor cocktail, 1 mM Na3VO4, and 1 mM phenylmethylsulfonyl fluoride. Lysates were clarified by centrifugation at 12,000 rpm for 1 min at 4°C. Glutathione-Sepharose beads (10–15 µg/sample) covered with GST-Rho-binding domain (RBD) fusion protein were then added to the supernatants and incubated at 4°C for 45 min. The GST-RBD beads were washed three times with Rho lysis buffer, and the captured proteins were diluted with 25 µl of Laemmli buffer, and subjected to electrophoresis on 15% SDS-polyacrylamide gels followed by Western blotting using an anti-Rho antibody.
Western Blotting
After treatments cells were scraped into Triton lysis buffer (30 mM HEPES, pH 7.4, 100 mM NaCl, 1 mM EGTA, 20 mM NaF, 1% Triton X-100, 1 mM Na3VO4, 1 mM phenylmethylsulphonyl fluoride, 20 µl/ml protease inhibitory cocktail (BD Biosciences, Mississauga, Ontario, Canada), the protein concentration was determined by the Bradford method (Bio-Rad Laboratories, Hercules, CA), and the samples were mixed in a 1:1 ratio with 2x Laemmli buffer and boiled for 5 min. For pMLC blots, the cells were lysed in ice-cold acetone containing 10% trichloroacetic acid and 10 mM dithiothreitol, followed by centrifugation for 10 min at 12,500 rpm at 4°C. The resulting pellet was washed with pure acetone, allowed to air dry, and dissolved in 60 µl of Laemmli sample buffer. Equal amounts of protein were separated on 10% SDS-polyacrylamide gel, and transferred to nitrocellulose membranes. Blots were blocked with Tris-buffered saline (TBS), containing 0.1% Tween 20 and 5% albumin for an hour. Membranes were incubated for an additional hour (or overnight for pMLC) with the primary antibody (in TBS-Tween plus 0.5% albumin), extensively washed, and incubated with the corresponding peroxidase-conjugated secondary antibody. After final washes immunoreactive bands were visualized with the enhanced chemiluminescence reaction.
Nuclear Extraction
Nuclear extracts were prepared from confluent layers of LLC-PK1 cells grown on 10-cm dishes, using NE-PER Nuclear Extraction Kit from Pierce Biotechnology (Rockford, IL) according to the manufacturer's recommendation. The nuclear extracts were collected, their protein concentration was determined, and samples of equal protein content were analyzed by Western blotting. Anti-histone antibody was used to check for equal loading of nuclear proteins.
Quantification of Cellular F-Actin Content
F-actin was measured by the rhodamine phalloidin extraction method, essentially as described (Pedersen and Hoffmann, 2002). This technique allows reliable determination of a few percent change in F-actin. Briefly, confluent LLC-PK1 cells grown on six-well plates were serum-deprived, treated with various inhibitors, and then fixed in Tris-buffered saline containing 2% paraformaldehyde. After repeated washes the cells were permeabilized with 0.1% saponin buffer and incubated in 250 µl of a 0.33 µM rhodamine phalloidin solution for an hour. The cells were then thoroughly washed, and the bound phalloidin was extracted by incubating the cells for 30 min with 2 ml of pure methanol per well. Rhodamine phalloidin fluorescence in the samples was determined by a Photon Technology cuvette fluorimeter (Lawrenceville, NJ) using 537 nm for excitation and 576 nm for emission.
Immunofluorescence Microscopy
Cells grown on coverslips were fixed with 4% paraformaldehyde for 30 min, washed with PBS, and incubated with 100 mmol/l glycine in PBS for 10 min. Cells were then permeabilized in PBS containing 0.1% Triton X-100, blocked for an hour with 3% albumin, and incubated with the primary antibody or antibodies (in case of costaining) for 1 h. After extensive washes, fluorescently labeled secondary antibodies were added for another hour. The coverslips were washed and then mounted on slides using Fluorescence Mounting Medium (DAKO, Carpinteria, CA). When directly labeled, FITC-conjugated mouse anti-Myc antibody was used together with another mouse primary antibody, and the cells were initially processed for staining with the unlabeled primary and corresponding secondary antibodies, blocked again with mouse serum (1:100), and then incubated with the directly labeled primary antibody for an hour. Samples were analyzed by an Olympus IX81 microscope (60x or 100x objectives, Melville, NY) coupled to an Evolution QEi Monochrome camera controlled by the QED InVivo Imaging software (Media Cybernetics, Silver Spring, MD). Images were processed by the ImagePro Plus 3DS 5.1 software (Media Cybernetics). Bars on the microscopic images correspond to 20 µm.
Quantification of Nuclear/Cytoplasmic Distribution of Proteins
Staining was quantified using the ImagePro Plus software: fluorescence intensities were determined at three random nuclear and cytoplasmic points along a line, or in three equal rectangular areas within the nucleus or the cytoplasm. An average of three determinations per cell was used, and the nuclear/cytoplasmic ratio was calculated. Ratios measured along lines or within rectangular areas were identical. Nuclei were independently visualized by DAPI staining. MRTF distribution was categorized as cytosolic or nuclear when the nucleus was clearly demarcated either by exclusion or accumulation of the label. Otherwise the distribution was regarded as even (or pancellular). To make these categories exact, distribution data were verified using the nuclear/cytoplasmic ratios as <0.75 (cytosolic), 0.75–1.25 (even), and >1.25 (nuclear). In the vast majority of cells within the nuclear category the ratio was >2.
Statistical Analysis
Data are presented as blots or images from at least three similar experiments or as the means ± SE for the number of experiments (n) indicated. Statistical significance was determined by Student's t test or one-way ANOVA using the GraphPad InStat software (San Diego, CA).
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
) indicates that contact disruption enhances contractility via both mono- and diphosphorylation of MLC. Importantly, MLC phosphorylation is a sustained response, because under Ca2+-free conditions peripheral pMLC levels remained high in 
60% of the cells for days (Figure 1, Bc and C), i.e., through the time course of our transfection and promoter studies (see below). To test whether Rho activity was required for increased monophosphorylation of MLC, 2 d before Ca2+ removal, cells were transfected with a Myc epitope–tagged dominant negative (T19N) Rho construct. Double staining for Myc and pMLC revealed that DN-Rho prevented the contact injury-triggered increase in pMLC (Figure 1B, e and e', and C). Moreover, the Rho kinase inhibitor Y-27632 also abolished the enhanced MLC phosphorylation (Figure 1Bd), suggesting that Rho-mediated ROK activation is indispensable for this process.
|
Myosin Phosphorylation Plays a Critical Role in the Ca2+ Removal–triggered Activation of the SMA Promoter
Although the activation of Rho is known to participate in the regulation of SRF-dependent gene expression, the downstream pathways mediating this effect have not been entirely elucidated. Particularly, the potential role of myosin activity or phosphorylation has not been addressed. Given the robust pMLC response upon contact disassembly, we sought to determine whether this event contributes to the activation of the SMA promoter. Initially we applied blebbistatin, a specific inhibitor of myosin ATPase (Straight et al., 2003). Figure 2A shows that pretreatment of the cells with blebbistatin did not affect the basal promoter activity but entirely prevented its activation by Ca2+ removal. Next we tested whether the drug also impacts the TGF-1–triggered stimulation and its contact-dependent potentiation. In agreement with our previous results, TGF-1 added to confluent layers caused only a modest increase in SMA promoter activity (Figure 2A). This effect was significantly reduced but not entirely abolished by blebbistatin. The combined treatment (Ca2+ removal + TGF-1) led to a robust rise in promoter activity, and this synergism was fully eliminated by blebbistatin. Although our previous results (Masszi et al., 2004) have implied that contact disruption does not act simply via increasing receptor availability for TGF-1, we further substantiated this point by testing the effect of Ca2+ removal on another TGF-–induced effect, the activation of the Smad-binding element (SBE; Felici et al., 2003; Figure 2B). TGF-1 exerted a similar stimulation of SBE in the presence or absence of calcium, indicating that altered receptor accessibility does not play a key role in the observed effects, and that the Ca2+-removal–induced potentiation is specific for the SMA promoter.
|
). AA-MLC effectively prevented the Ca2+-removal–induced rise in peripheral pMLC (Figure 2C), implying that this mutant acts as a dominant negative (DN-MLC). This conclusion is supported also by our previous observation using other stimuli, including osmotic stress and depolarization. To assess the effect of MLC phosphorylation per se on the activation of the promoter, we cotransfected the cells with DN-MLC along with SMA-Luc and subjected them to various stimuli. DN-MLC nearly abolished the Ca2+ deprivation–induced increase in promoter activity, and strongly abrogated the synergistic effect induced by Ca2+ removal and TGF-1 (Figure 2D). To substantiate these results, we performed two kinds of control experiments. First, to verify that the type of the expression vector was not critical, and that the observed effect was indeed exerted on the promoter, we repeated these experiments using an alternative (pGL3) plasmid harboring the same 765-base pair promoter sequence. DN-MLC effectively inhibited the Ca2+ depletion–induced luciferase response in this system as well (Figure 2E). Second, to verify that the mutation is indeed the determining factor for the inhibitory effect, cells were transfected with the Myc-tagged WT (T18, S19) MLC as well (Figure 2F). Overexpression of WT myosin had no effect on the basal promoter activity and did not alter its activation by Ca2+ removal. Together these data imply that myosin activity as well as myosin phosphorylation are important contributors to the contact-dependent regulation of the SMA promoter. Together these experiments strongly argued for the participation of myosin activity and activation in the regulation of the SMA promoter.
Because the level of actin polymerization is known to regulate CArG-dependent genes, we considered that the effect of myosin inhibition might be, at least partially, due to an impact on F-actin. Phalloidin staining reveled that in confluent cultures LLC-PK1 cells contained relatively few and fine stress fibers near their ventral surface, and punctate F-actin distribution corresponding to microvilli at their apical surface. Blebbistatin induced substantial stress fiber disassembly in accord with our previous findings (Di Ciano-Oliveira et al., 2005) and a decrease in microvillar F-actin labeling (Figure 3A, top and bottom). These observations suggest that basal myosin activity is necessary for normal F-actin arrangement, but they do not provide quantitative information about any potential change in the size of the F-actin pool. To address this issue, we compared the F-actin levels in control and blebbistatin-treated cells using a phalloidin extraction assay. As shown on Figure 3C, blebbistatin did not alter the total F-actin level, in sharp contrast with the effect of the actin monomer-sequestering drug, Latrunculin B, which was applied as a positive control for the assay. Next we assessed the effect of DN-MLC on the actin skeleton. As opposed to blebbistatin treatment, we were not able to detect any obvious change in the F-actin arrangement of DN-MLC–expressing (Myc-positive) cells compared with their nontransfected neighbors (Figure 3B). This finding is consistent with the preservation of basal myosin activity in these cells. To assess the impact on F-actin, we had to generate a cell population, in which the majority of cells expressed DN-MLC. Using a selection protocol, we obtained a population with >85% expressors. In these cells there was a slight (9%) decrease in the total F-actin compared with nonexpressors. Neither blebbistatin nor DN-MLC altered total actin expression (Figure 3D). Taken together, these data show that alteration in myosin activity markedly suppressed the activation promoter without (blebbistatin) or with a small (DN-MLC) change in the total F-actin. Although these experiments do not rule out that myosin might impact on specific actin pools or on stimulus-induced F-actin polymerization, they suggest that other mechanisms are likely to contribute to the overall effect of myosin inhibition (see Discussion).
|
), although both this possibility and the involvement of the Rho pathway in this process remain controversial (Cen et al., 2004). Therefore we asked whether contact disruption affects SRF localization. Figure 4A shows that SRF exhibited nuclear accumulation even in resting, nonstimulated cells. Interestingly, nuclear distribution was more pronounced in subconfluent cultures (not shown), whereas upon reaching confluence, the cytosolic staining increased concomitant with a drop in nuclear labeling. Nonetheless, the latter still remained significantly higher than the extranuclear signal (Figure 4A). Ca2+ depletion of the cultures caused a sizable and time-dependent increase in nuclear SRF staining. To verify that this effect was not an optical artifact due to cell contraction–associated cytosolic shrinkage, we performed Western blots on nuclear extracts obtained from control and Ca2+-deprived cultures. Figure 4B shows that an increase in nuclear SRF upon Ca2+ removal was detected also by this technique. Next we tested whether a Myc-tagged constitutively active Rho mutant was able to impact on SRF localization. We observed enhanced nuclear accumulation of SRF in active Rho-transfected cells (Figure 4C). Curiously however, this effect was clearly visible only in cells that showed a modest Rho expression (as visualized by Myc staining), whereas it was not apparent in cells with high level (and possibly longer lasting) expression of active Rho. This finding suggests that the increase in nuclear SRF accumulation may be transient, or various Rho-dependent pathways might be involved both in nuclear import and export processes. Expression of DN-Rho substantially mitigated or completely prevented the increase in nuclear SRF (Figure 4D). Indeed in many DN-Rho–expressing, stimulated cells the level of nuclear SRF was lower than in nonstimulated controls (not shown). Finally we tested whether inhibition of myosin phosphorylation might impact on SRF traffic. To this end cells were cotransfected with DN-MLC, and after Ca2+ removal doubly stained for Myc (DN-MLC) and SRF. DN-MLC expression appeared to mitigate the increase in nuclear SRF accumulation (Figure 4E). To quantify the results, the fluorescence intensity of SRF staining was determined in the nucleus and cytosol of individual (control or DN-MLC expressing) cells and the nucleocytoplasmic ratio was calculated under various conditions (Figure 4F). Under resting conditions in control cells, SRF exhibited a 1.4-fold nuclear accumulation over the cytosol, which upon Ca2+ removal increased to 2.1-fold. The expression of DN-MLC did not have a significant effect on the resting SRF distribution, but it reduced the Ca2+ deprivation–induced rise by 60%. These data are consistent with some contribution of myosin phosphorylation in the contact-dependent traffic of SRF. However, given the fact that there is a substantial amount of SRF in the nucleus even under resting conditions, and that the effect of DN-MLC was only partial, we continued to examine the contribution of another Rho-dependent process, namely localization of MRTF.
|
8-fold) increase in nuclear MRTF-B accumulation (Figure 5, B and D, a and a'). Overall >80% of Rho-transfected cells showed pancellular or fully nuclear distribution, whereas this fraction was only 15% in the control (GFP expressing) cells. To verify that the changes in actin organization are indeed able to redistribute MRTF-B in kidney epithelial cells, we used jasplakinolide, a potent actin-polymerizing agent. Similar to active Rho, this drug also provoked robust nuclear accumulation of MRTF-B (Figure 5Db).
|
Next we studied whether forced F-actin polymerization or MRTF overexpression might result in SMA promoter activation and protein expression in LLC-PK1 epithelial cells. Jasplakinolide (in the absence of any other stimulus) was able to provoke a large increase in SMA promoter activity (Figure 6A) and induced SMA protein expression (Figure 6B), indicating that drastic actin polymerization is sufficient to trigger myofibroblast transformation of normal epithelial cells. Consistent with an important role of MRTF in the regulation of SMA expression, transfection of MRTF isoforms led to a robust increase in the SMA promoter activity (Figure 6C), which—in agreement with the localization data—was stronger in case of MRTF-A than MRTF-B. Further, expression of the MRTF constructs was often accompanied with SMA protein expression, as verified by double immunostaining for SMA and the FLAG epitope (Figure 6E). The expression of SMA was robust considering that transient transfection of a few percent of the cells with MRTF-A or B resulted in SMA synthesis that was readily detectable in total cell lysates by Western blotting (Figure 6D). Control or mock-transfected epithelial cells never expressed SMA (Figure 6, D and E).
|
Contact Integrity Regulates the Nucleocytoplasmic Transfer of Endogenous MRTF in a Rho- and MLC Phosphorylation–dependent Manner
To substantiate the relevance of these findings, we followed the localization of endogenous MRTF using a polyclonal antibody raised against BSAC, the mouse homologue of MKL1/MRTF-A. In resting LLC-PK1 cells endogenous MRTF showed entirely cytosolic distribution with strong nuclear exclusion (Figure 7, Aa and B). Expression of constitutive active Rho redistributed MRTF into the nucleus (Figure 7A, c and c', and B), verifying the Rho responsiveness of the endogenous protein in this epithelial setting. Importantly, Ca2+ removal also caused a marked nuclear shift: after this treatment 
16% of the cells exhibited strong nuclear accumulation, whereas the nuclear exclusion disappeared in the majority of cells (Figure 7, Ab and B). Dominant negative Rho strongly mitigated the contact disruption–induced nuclear transfer (Figure 7, A, d–d'', and B). Importantly, expression of DN-MLC significantly suppressed the translocation as well, suggesting the contribution of myosin phosphorylation in the process (Figure 7, A, e–e'', and B).
|
1. To test this assumption, we compared MRTF distribution in confluent and nonconfluent cultures exposed to TGF-1 for various times. Endogenous MRTF was entirely cytosolic in confluent cultures (Figure 8A, top panels). Treatment of intact confluent layers with TGF-1 (0–24 h) did not induce nuclear translocation of MRTF, and most cells showed no change in MRTF localization at all, whereas some exhibited a punctate, perinuclear labeling. A radically different picture was observed in subconfluent cultures. Under resting condition, 75% of the cells located at the free edges of cellular islands showed cytosolic MRTF staining, whereas 17% showed clear nuclear accumulation and 8% had even cytosolic and nuclear distribution (Figure 8A, bottom panels and graph). The extent of the nuclear accumulation of MRTF in subconfluent layers was in good agreement with the values obtained in cells in which the contacts were disassembled by Ca2+ removal. In cells located in the intact inner regions of these multicellular islands, MRTF was fully cytosolic. In subconfluent layers (as opposed to the confluent ones), TGF-1 exposure induced a dramatic change in MRTF distribution: in cells at the free edges, perinuclear MRTF condensation was apparent after 1 h treatment (not shown), whereas after 6 h, 95% of peripheral cells showed strong nuclear accumulation of MRTF (Figure 8A). Cells in rows adjacent to the peripheral row also showed increased nuclear localization (Figure 8A), whereas in the inner areas MRTF remained cytosolic (not shown). To our surprise nuclear accumulation of MRTF in the peripheral cells was transient: after 24 h of TGF-1 treatment, the response significantly decreased: only 25% of the cells showed clear nuclear MRTF localization, whereas even distribution or punctate, perinuclear labeling was visible in 12% of the cells (Figure 8A).
|
1 might not be able to elicit large or sustained MLC phosphorylation in fully confluent layers. Indeed, TGF-1 exposure for 16 h had no discernable effect on phospho-MLC content when the cytokine was added to confluent layers (Figure 8B). In contrast substantial phospho-MLC staining was observed at the free edges of cells located in the periphery of untreated subconfluent islands (Figure 8B), i.e., at the same locus where cells are susceptible to TGF-1–induced SMA expression. The phospho-MLC signal at these sites appeared to further increase upon TGF-1 treatment. Consistent with these findings, acute Ca2+ removal caused robust myosin phosphorylation in confluent layers (as visualized by Western blotting), whereas short-term treatment with TGF-1 caused a much smaller response. Nonetheless, TGF-1 was able to cause a significant and rapid albeit transient MLC phosphorylation, indicating that the confluent monolayer remained responsive to the cytokine. Ca2+ removal combined with TGF-1 gave the most robust effect on MLC phosphorylation (Figure 8C). In addition to Ca2+ removal and subconfluence, the third, and from a pathological standpoint possibly the most relevant, model of contact disruption is mechanical wounding of a confluent monolayer. Cells at the wound edge showed marked MLC phosphorylation (Figure 8D). Interestingly, at this location a number of cells exhibited nuclear accumulation of endogenous MRTF as well (Figure 8D).
Finally we tested whether interfering with myosin phosphorylation indeed impacts on SMA protein expression. As shown on Figure 8E DN-MLC reduced the number of SMA-expressing cells in sparse, TGF-1–treated cultures. Under these conditions approx. 22% of control cells expressed SMA, whereas this number dropped more than fourfold (approx. 4%) in DN-MLC–expressing cells (Figure 8E).
Taken together, the nuclear accumulation of endogenous MRTF is regulated in a cell contact– and contractility-dependent manner in tubular cells, and impaired contact integrity plays a deterministic role in the regulation of MRTF distribution upon TGF-1 treatment.
MRTF Is a Central Contributor to the Cell Contact–regulated and TGF-1–modulated Activation of the SMA Promoter
To address whether in our system MRTF has a causal role in the contact injury–dependent SMA promoter response, and its potentiation by TGF-1, we transfected the cells with a mutant FLAG-tagged myocardin (C585), which lacks the transactivation domain, and has been shown to act as dominant negative against each member of the MRTF family (Wang et al., 2001). This mutant showed spontaneous accumulation in the nucleus and was present in the cytosol too, as revealed by immunostaining with an anti-FLAG antibody (Figure 9A). Importantly, expression of C585 abolished the Ca2+ deprivation–triggered increase in promoter activity and strongly suppressed the synergism between contact disassembly and TGF-1 (Figure 9B). These observations suggest that endogenous MRTF activity is a central target of the cell contact– and TGF-1–dependent regulation of the SMA promoter, and it plays an indispensable role in myofibroblast differentiation of kidney tubular cells.
|
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
). Injury or absence of intercellular contacts exerts a permissive and potentiating effect on the transdifferentiation of epithelial cells to myofibroblasts (Masszi et al., 2004). This phenomenon may have a key importance from a pathobiologic standpoint: although intact epithelia may be partially resistant to the fibrogenic effect of TGF-1, an initial injury may render the wounded region susceptible for this cytokine, thereby generating focally transformed areas. From these foci the process can spread to neighboring regions. Furthermore, the development of myofibroblasts in the wound has been associated with a change in the type of the expressed cadherins (Hinz et al., 2004). With this scenario in mind, the present study aimed to identify contact-dependent mechanisms that can facilitate EMT. We found that contact disassembly causes Rho activation and ROK-mediated MLC phosphorylation. These events then contribute to the nuclear redistribution of SRF and mainly its coactivator, MRTF, which in turn activate the SMA promoter, and strongly synergize with the TGF-1–induced SMA protein expression.
Cell Contacts, Rho Activation, and MLC Phosphorylation
Our finding that the Ca2+ removal–induced disruption of cell junctions activates Rho is in good accord with the reported converse phenomenon, i.e., that during the Ca2+-triggered formation of intercellular junctions Rho activity is gradually down-regulated (Noren et al., 2003). The mechanism whereby the destabilization of tight or adherent junctions stimulates Rho remains to be elucidated. It is noteworthy that recently a Rho-specific guanine nucleotide exchange factor, the Dbl family member GEF-H1/Lfc has been found to localize to the tight junction, where it regulates paracellular permeability, a myosin-modulated function (Benais-Pont et al., 2003). Future studies should address whether GEF-H1 is activated by contact disruption. In tubular cells, contact disassembly led to rapid and long-lasting MLC phosphorylation, which was most prominent at the cell periphery. This response was mediated by the Rho/ROK pathway because it was inhibited by genetic or pharmacological interference with this signaling route. The same maneuvers abolished the Ca2+ removal–induced activation of the SMA promoter as well, indicating that the Rho/ROK pathway has a key role in cell contact–dependent regulation of gene expression. In addition to the spatially restricted activation of Rho, junctional ROK and/or myosin localization or accumulation may also contribute to the focal MLC phosphorylation. Indeed, a subpool of ROK was found to be associated with the adherens junctions (Walsh et al., 2001), and a peripheral myosin ring is present in epithelial cells (Ivanov et al., 2004, 2005). Thus, each component of the Rho/ROK/MLC pathways can be junction-associated, facilitating the preferential activation of this particular downstream Rho pathway at the contacts.
Myosin Phosphorylation and the Regulation of the SMA Promoter
Rho has been shown to increase the transcriptional activity of SRF on those target genes, including SMA, whose promoter harbors CArG boxes (Hill et al., 1995; Mack et al., 2001; Masszi et al., 2003). Elegant studies have revealed that the effect of Rho is mediated by cytoskeletal reorganization, a key component of which is enhanced F-actin polymerization (Miralles et al., 2003). So far two downstream Rho effector pathways have been implicated in SRF-dependent transcription: the activation of the formin protein mDia, which induces net F-actin polymerization (Copeland and Treisman, 2002) and the activation of the Rho/ROK/LIM kinase/cofilin phosphorylation pathway, which stabilizes F-actin due to decreased severing (Geneste et al., 2002). The former mechanism was predominant in fibroblasts, whereas both were critical in neuron-like PC12 cells. Our studies point to the importance of a third Rho effector pathway, namely ROK-dependent MLC phosphorylation. This mechanism, at least in our epithelial cells, seems to be an important contributor, because the myosin inhibitor blebbistatin or a phosphorylation–incompetent DN myosin mutant abolished the contact disruption-provoked SMA promoter expression, eliminated the synergism between contact injury and TGF-1 on the promoter, and suppressed SMA protein expression. Peripheral myosin activity (junctional contractility) has been proposed to participate in the regulation of various functions including paracellular permeability (Turner, 2000), junction remodeling (Ivanov et al., 2004, 2005; Shewan et al., 2005), cell scattering (de Rooij et al., 2005), morphogenesis (Bertet et al., 2004), and closure of epithelial wounds (Darenfed and Mandato, 2005). Our data assign yet another critical role for this process: the regulation of SRF-dependent gene expression (Figure 10). This mechanism efficiently couples the mechanical and genetic responses to wounding: Formation of actin–myosin complexes triggers contractile wound closure and at the same time initiates genetic reprogramming, leading to enhanced generation of extracellular matrix proteins and contractile elements.
|
) and has been associated with increased SMA expression (Hinz et al., 2001).
The original question then translates into asking how myosin activity impacts on MRTF localization or activity (Figure 10). Several possibilities can be evoked: 1) MRTF localization is regulated by the G/F actin ratio. Binding of monomeric actin (presumably through a yet unidentified protein) to MRTF prevents its translocation to the nucleus whereas actin polymerization removes G-actin from MRTF, thereby exposing its nuclear localization sequence (Miralles et al., 2003; Posern et al., 2004). It is conceivable that myosin activity, which promotes actin filament bundling, can also "steal away" monomeric actin from MRTF, or the formation of actin–myosin complexes may specifically reduce the MRTF-binding competent pool of actin. Indeed, blebbistatin, which inhibits basal myosin activity as well, promoted the dissociation of stress fibers. However we found no evidence that blebbistatin would significantly decrease the total F-actin pool. Furthermore, using DN-MLC, we did not observe any major change in the actin skeleton organization and only a modest reduction in F-actin. In this regard, it is worth pointing out that both the monomer-sequestering drug latrunculin B and the barbed end capper cytochalasin D induce strong F-actin disassembly, yet the former inhibits while the latter triggers the nuclear translocation of MRTF (Miralles et al., 2003). This observation suggests that the critical factor is not necessarily the content of F-actin or the F/G actin ratio, but rather the interaction of G-actin with inhibitors or proteins, which will determine whether G-actin can bind to MRTF. Taken together our observations suggest that a gross alteration in the G/F actin ratio is unlikely to be required for the inhibition of SMA expression by suppressed myosin phosphorylation. Indeed, several observations suggest that Rho impacts on SRF signaling not exclusively via actin polymerization: Certain Rho mutants stimulate SRF without inducing stress fibers formation (Sahai et al., 1998; Zohar et al., 1998), and a newly described Rho effector hCNK1 activates SRF without promoting stress fiber assembly (Jaffe et al., 2004). Nonetheless our data do not rule out the possibility that inhibition of myosin might interfere with stimulus-induced localized F-actin assembly. Clearly, future studies should directly address whether myosin activity impacts on the formation of the actin/actin-binding protein/MRTF complexes. 2) Another potential mechanism is that myosin, as a force-generating protein, might be required for the efficient nuclear import or retention of MRTF. There is accumulating evidence that both the microtubule and the microfilament cytoskeleton is involved in the nuclear import of certain proteins (Campbell and Hope, 2003). Recently, endothelial MLC kinase has been shown to regulate the nuclear translocation of NF
B and the consequent reporter gene activation (Wadgaonkar et al., 2005). Although the underlying mechanism remains to be clarified, a similar process might participate in MRTF translocation as well, except in LLC-PK1 cells the predominant enzyme responsible for MLC phosphorylation is ROK and not MLCK (Szaszi et al., 2005). 3) Finally, myosin may affect other processes in addition to MRTF translocation. We have previously shown that upon contact injury E-cadherin is degraded allowing the liberation of -catenin, which potentiates the activation of the SMA promoter (Masszi et al., 2004). Importantly, Ivanov et al. (2004) have shown that myosin activity is essential for the contact disassembly–induced internalization of E-cadherin, and blebbistatin maintains E-cadherin at the cell surface. Similarly, the Src-mediated delocalization of E-cadherin from the AJ also requires MLC phosphorylation (Avizienyte et al., 2004). Taken together, junction stabilization by myosin inhibition may contribute to the inhibition of the SMA promoter.
MRTF and EMT
The present work identifies MRTF as a central factor in mesenchymal/myofibroblast transdifferentiation of epithelial cells. This conclusion is supported by the findings that 1) overexpression of MRTF is sufficient to induce SMA promoter activation and protein expression in tubular cells; 2) induction of robust actin polymerization induces nuclear accumulation of MRTF concomitant with SMA expression, and 3) DN-myocardin prevents the Ca2+ depletion–induced promoter activation and the synergism between contact injury and TGF-1. In nonstimulated LLC-PK1 cells endogenous MRTF (as visualized by the anti-BSAC antibody) was cytosolic. Interestingly, the heterologously expressed MRTF-A was predominantly nuclear, whereas MRTF-B localized mainly to the cytosol. In contrast, both MRTF-A and -B were cytosolic in fibroblasts, pointing to tissue-specific differences in localization, presumably due to a different set of actin-binding proteins. Indeed, recently a striated muscle-specific actin- and MRTF-binding protein (STARS) has been identified (Kuwahara et al., 2005). Further studies are warranted to investigate the contribution of endogenous MRTF isoforms to EMT.
We observed that TGF-1 was unable to induce MRTF translocation in fully confluent layers, but it enhanced nuclear accumulation after contact disassembly. This finding implies that MRTF localization is one of the key target mechanisms that underlies the synergy between TGF-1 and contact injury. Presumably, the strong, contact-dependent Rho activation is indispensable for the efficient nuclear accumulation of MRTF. On the other hand, moderate translocation of endogenous MRTF may not be sufficient to induce SMA expression, because cells adjacent to the wound are not transformed in the absence of TGF-1. The SMA promoter harbors several transcriptional regulatory elements, including the SRF/MRTF-binding CArG-boxes, the Kruppel factor-binding TGF- control element (TCE), and the TGF-–responsive SBE (Hautmann et al., 1997; Hu et al., 2003; Liu et al., 2003b). Accordingly, the promoter can be collectively regulated by contact-dependent (Rho-mediated) and TGF-1–dependent (partially Rho-independent) pathways (Figure 10). Interestingly MRTF may have multiple roles: in addition to forming a ternary complex with SRF and CArG boxes, it was found to bind to the SMAD proteins too, and thus it might facilitate transcription through the SBE (Qiu et al., 2005). Moreover SMADs were shown to associate with -catenin as well (Tian and Phillips, 2002). These multiple inputs then can culminate in robust promoter activation. Finally, we observed that even under the maximally effective two-hit conditions, MRTF accumulation in the nucleus is transient. Future studies should investigate the regulation of the nuclear export of MRTF.
In summary, we propose that the contact injury-induced, Rho-ROK-phospho-myosin–mediated MRTF translocation represents a central signaling pathway in transdifferentiation of epithelial cells, and thereby in the pathogenesis of organ fibrosis.
|
ACKNOWLEDGMENTS |
|---|
|
Footnotes |
|---|
These authors contributed equally to this work. 
Address correspondence to: András Kapus (kapusa{at}smh.toronto.on.ca)
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Benais-Pont, G., Punn, A., Flores-Maldonado, C., Eckert, J., Raposo, G., Fleming, T. P., Cereijido, M., Balda, M. S., Matter, K. (2003). Identification of a tight junction-associated guanine nucleotide exchange factor that activates Rho and regulates paracellular permeability. J. Cell Biol 160, 729–740.
Bertet, C., Sulak, L., Lecuit, T. (2004). Myosin-dependent junction remodelling controls planar cell intercalation and axis elongation. Nature 429, 667–671.[CrossRef][Medline]
Bottinger, E. P. and Bitzer, M. (2002). TGF-beta signaling in renal disease. J. Am. Soc. Nephrol 13, 2600–2610.
Camoretti-Mercado, B., et al. (2000). Physiological control of smooth muscle-specific gene expression through regulated nuclear translocation of serum response factor. J. Biol. Chem 275, 30387–30393.
Campbell, E. M. and Hope, T. J. (2003). Role of the cytoskeleton in nuclear import. Adv. Drug. Deliv. Rev 55, 761–771.[CrossRef][Medline]
Cen, B., Selvaraj, A., Burgess, R. C., Hitzler, J. K., Ma, Z., Morris, S. W., Prywes, R. (2003). Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes. Mol. Cell. Biol 23, 6597–6608.
Cen, B., Selvaraj, A., Prywes, R. (2004). Myocardin/MKL family of SRF coactivators: key regulators of immediate early and muscle specific gene expression. J. Cell Biochem 93, 74–82.[CrossRef][Medline]
Chaponnier, C. and Gabbiani, G. (2004). Pathological situations characterized by altered actin isoform expression. J. Pathol 204, 386–395.[CrossRef][Medline]
Copeland, J. W. and Treisman, R. (2002). The diaphanous-related formin mDia1 controls serum response factor activity through its effects on actin polymerization. Mol. Biol. Cell 13, 4088–4099.
Darenfed, H. and Mandato, C. A. (2005). Wound-induced contractile ring: a model for cytokinesis. Biochem. Cell Biol 83, 711–720.[CrossRef][Medline]
de Rooij, J., Kerstens, A., Danuser, G., Schwartz, M. A., Waterman-Storer, C. M. (2005). Integrin-dependent actomyosin contraction regulates epithelial cell scattering. J. Cell Biol 171, 153–164.
Desmouliere, A., Chaponnier, C., Gabbiani, G. (2005). Tissue repair, contraction, and the myofibroblast. Wound Repair. Regen 13, 7–12.[CrossRef][Medline]
Di Ciano-Oliveira, C., Lodyga, M., Fan, L., Szaszi, K., Hosoya, H., Rotstein, O. D., Kapus, A. (2005). Is myosin light-chain phosphorylation a regulatory signal for the osmotic activation of the Na+-K+-2Cl– cotransporter? Am. J. Physiol. Cell Physiol 289, C68–C81.
Di Ciano-Oliveira, C., Sirokmany, G., Szaszi, K., Arthur, W. T., Masszi, A., Peterson, M., Rotstein, O. D., Kapus, A. (2003). Hyperosmotic stress activates Rho: differential involvement in Rho kinase-dependent MLC phosphorylation and NKCC activation. Am. J. Physiol. Cell Physiol 285, C555–C566.
Du, K. L., Chen, M., Li, J., Lepore, J. J., Mericko, P., Parmacek, M. S. (2004). Megakaryoblastic leukemia factor-1 transduces cytoskeletal signals and induces smooth muscle cell differentiation from undifferentiated embryonic stem cells. J. Biol. Chem 279, 17578–17586.
Du, K. L., Ip, H. S., Li, J., Chen, M., Dandre, F., Yu, W., Lu, M. M., Owens, G. K., Parmacek, M. S. (2003). Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol. Cell. Biol 23, 2425–2437.
Fan, J. M., Ng, Y. Y., Hill, P. A., Nikolic-Paterson, D. J., Mu, W., Atkins, R. C., Lan, H. Y. (1999). Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 56, 1455–1467.[CrossRef][Medline]
Felici, A., Wurthner, J. U., Parks, W. T., Giam, L. R., Reiss, M., Karpova, T. S., McNally, J. G., Roberts, A. B. (2003). TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling. EMBO J 22, 4465–4477.[CrossRef][Medline]
Frixione, E., Lagunes, R., Ruiz, L., Urban, M., Porter, R. M. (2001). Actin cytoskeleton role in the structural response of epithelial (MDCK) cells to low extracellular Ca2+. J. Muscle Res. Cell Motil 22, 229–242.[CrossRef][Medline]
Gabbiani, G. (2003). The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol 200, 500–503.[CrossRef][Medline]
Geneste, O., Copeland, J. W., Treisman, R. (2002). LIM kinase and Diaphanous cooperate to regulate serum response factor and actin dynamics. J. Cell Biol 157, 831–838.
Hautmann, M. B., Madsen, C. S., Owens, G. K. (1997). A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements. J. Biol. Chem 272, 10948–10956.
Hill, C. S., Wynne, J., Treisman, R. (1995). The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81, 1159–1170.[CrossRef][Medline]
Hinz, B., Mastrangelo, D., Iselin, C. E., Chaponnier, C., Gabbiani, G. (2001). Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am. J. Pathol 159, 1009–1020.
Hinz, B., Pittet, P., Smith-Clerc, J., Chaponnier, C., Meister, J. J. (2004). Myofibroblast development is characterized by specific cell-cell adherens junctions. Mol. Biol. Cell 15, 4310–4320.
Hu, B., Wu, Z., Phan, S. H. (2003). Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression. Am. J. Respir. Cell Mol. Biol 29, 397–404.
Ivanov, A. I., Hunt, D., Utech, M., Nusrat, A., Parkos, C. A. (2005). Differential roles for actin polymerization and a myosin II motor in assembly of the epithelial apical junctional complex. Mol. Biol. Cell 16, 2636–2650.
Ivanov, A. I., McCall, I. C., Parkos, C. A., Nusrat, A. (2004). Role for actin filament turnover and a myosin II motor in cytoskeleton-driven disassembly of the epithelial apical junctional complex. Mol. Biol. Cell 15, 2639–2651.
Iwano, M., Plieth, D., Danoff, T. M., Xue, C., Okada, H., Neilson, E. G. (2002). Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest 110, 341–350.[CrossRef][Medline]
Iwasaki, T., Murata-Hori, M., Ishitobi, S., Hosoya, H. (2001). Diphosphorylated MRLC is required for organization of stress fibers in interphase cells and the contractile ring in dividing cells. Cell Struct. Funct 26, 677–683.[CrossRef][Medline]
Jaffe, A. B., Aspenstrom, P., Hall, A. (2004). Human CNK1 acts as a scaffold protein, linking Rho and Ras signal transduction pathways. Mol. Cell Biol 24, 1736–1746.
Kalluri, R. and Neilson, E. G. (2003). Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest 112, 1776–1784.[CrossRef][Medline]
Kuwahara, K., Barrientos, T., Pipes, G. C., Li, S., Olson, E. N. (2005). Muscle-specific signaling mechanism that links actin dynamics to serum response factor. Mol. Cell. Biol 25, 3173–3181.
Lee, J. M., Dedhar, S., Kalluri, R., Thompson, E. W. (2006). The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol 172, 973–981.
Liu, H. W., et al. (2003a). The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor. Am. J. Respir. Cell Mol. Biol 29, 39–47.
Liu, Y. (2004). Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J. Am. Soc. Nephrol 15, 1–12.
Liu, Y., Sinha, S., Owens, G. (2003b). A transforming growth factor-beta control element required for SM alpha-actin expression in vivo also partially mediates GKLF-dependent transcriptional repression. J. Biol. Chem 278, 48004–48011.
Mack, C. P., Somlyo, A. V., Hautmann, M., Somlyo, A. P., Owens, G. K. (2001). Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J. Biol. Chem 276, 341–347.
Mack, C. P., Thompson, M. M., Lawrenz-Smith, S., Owens, G. K. (2000). Smooth muscle alpha-actin CArG elements coordinate formation of a smooth muscle cell-selective, serum response factor-containing activation complex. Circ. Res 86, 221–232.
Masszi, A., Di Ciano, C., Sirokmany, G., Arthur, W. T., Rotstein, O. D., Wang, J., McCulloch, C. A., Rosivall, L., Mucsi, I., Kapus, A. (2003). Central role for Rho in TGF-beta1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition. Am. J. Physiol. Renal Physiol 284, F911–F924.
Masszi, A., Fan, L., Rosivall, L., McCulloch, C. A., Rotstein, O. D., Mucsi, I., Kapus, A. (2004). Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. Am. J. Pathol 165, 1955–1967.
Miralles, F., Posern, G., Zaromytidou, A. I., Treisman, R. (2003). Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113, 329–342.[CrossRef][Medline]
Noren, N. K., Arthur, W. T., Burridge, K. (2003). Cadherin engagement inhibits RhoA via p190RhoGAP. J. Biol. Chem 278, 13615–13618.
Pedersen, S. F. and Hoffmann, E. K. (2002). Possible interrelationship between changes in F-actin and myosin II, protein phosphorylation, and cell volume regulation in Ehrlich ascites tumor cells. Exp. Cell Res 277, 57–73.[CrossRef][Medline]
Posern, G., Miralles, F., Guettler, S., Treisman, R. (2004). Mutant actins that stabilise F-actin use distinct mechanisms to activate the SRF coactivator MAL. EMBO J 23, 3973–3983.[CrossRef][Medline]
Qiu, P., Ritchie, R. P., Fu, Z., Cao, D., Cumming, J., Miano, J. M., Wang, D. Z., Li, H. J., Li, L. (2005). Myocardin enhances Smad3-mediated transforming growth factor-beta1 signaling in a CArG box-independent manner: Smad-binding element is an important cis element for SM22alpha transcription in vivo. Circ. Res 97, 983–991.
Sahai, E., Alberts, A. S., Treisman, R. (1998). RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation. EMBO J 17, 1350–1361.[CrossRef][Medline]
Sasazuki, T., et al. (2002). Identification of a novel transcriptional activator, BSAC, by a functional cloning to inhibit tumor necrosis factor-induced cell death. J. Biol. Chem 277, 28853–28860.
Selvaraj, A. and Prywes, R. (2003). Megakaryoblastic leukemia-1/2, a transcriptional co-activator of serum response factor, is required for skeletal myogenic differentiation. J. Biol. Chem 278, 41977–41987.
Shewan, A. M., Maddugoda, M., Kraemer, A., Stehbens, S. J., Verma, S., Kovacs, E. M., Yap, A. S. (2005). Myosin 2 is a key Rho kinase target necessary for the local concentration of E-cadherin at cell-cell contacts. Mol. Biol. Cell 16, 4531–4542.
Somogyi, K. and Rorth, P. (2004). Evidence for tension-based regulation of Drosophila MAL and SRF during invasive cell migration. Dev. Cell 7, 85–93.[CrossRef][Medline]
Sotiropoulos, A., Gineitis, D., Copeland, J., Treisman, R. (1999). Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell 98, 159–169.[CrossRef][Medline]
Straight, A. F., Cheung, A., Limouze, J., Chen, I., Westwood, N. J., Sellers, J. R., Mitchison, T. J. (2003). Dissecting temporal and spatial control of cytokinesis with a myosin II Inhibitor. Science 299, 1743–1747.
Strutz, F., Okada, H., Lo, C. W., Danoff, T., Carone, R. L., Tomaszewski, J. E., Neilson, E. G. (1995). Identification and characterization of a fibroblast marker: FSP1. J. Cell Biol 130, 393–405.
Szaszi, K., Sirokmany, G., Di Ciano-Oliveira, C., Rotstein, O. D., Kapus, A. (2005). Depolarization induces Rho-Rho kinase-mediated myosin light chain phosphorylation in kidney tubular cells. Am. J. Physiol. Cell Physiol 289, C673–C685.
Tian, Y. C. and Phillips, A. O. (2002). Interaction between the transforming growth factor-beta type II receptor/Smad pathway and beta-catenin during transforming growth factor-beta1-mediated adherens junction disassembly. Am. J. Pathol 160, 1619–1628.
Turner, J. R. (2000). ‘Putting the squeeze’ on the tight junction: understanding cytoskeletal regulation. Semin. Cell Dev. Biol 11, 301–308.[CrossRef][Medline]
Wadgaonkar, R., Linz-McGillem, L., Zaiman, A. L., Garcia, J. G. (2005). Endothelial cell myosin light chain kinase (MLCK) regulates TNFalpha-induced NFkappaB activity. J. Cell Biochem 94, 351–364.[CrossRef][Medline]
Walsh, S. V., Hopkins, A. M., Chen, J., Narumiya, S., Parkos, C. A., Nusrat, A. (2001). Rho kinase regulates tight junction function and is necessary for tight junction assembly in polarized intestinal epithelia. Gastroenterology 121, 566–579.[CrossRef][Medline]
Wang, D., Chang, P. S., Wang, Z., Sutherland, L., Richardson, J. A., Small, E., Krieg, P. A., Olson, E. N. (2001). Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105, 851–862.[CrossRef][Medline]
Wang, D. Z., Li, S., Hockemeyer, D., Sutherland, L., Wang, Z., Schratt, G., Richardson, J. A., Nordheim, A., Olson, E. N. (2002). Potentiation of serum response factor activity by a family of myocardin-related transcription factors. Proc. Natl. Acad. Sci. USA 99, 14855–14860.
Yang, J. and Liu, Y. (2001). Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am. J. Pathol 159, 1465–1475.
Zohar, M., Teramoto, H., Katz, B. Z., Yamada, K. M., Gutkind, J. S. (1998). Effector domain mutants of Rho dissociate cytoskeletal changes from nuclear signaling and cellular transformation. Oncogene 17, 991–998.[CrossRef][Medline]
This article has been cited by other articles:
|
|
 |
|
  E. Kakiashvili, P. Speight, F. Waheed, R. Seth, M. Lodyga, S. Tanimura, M. Kohno, O. D. Rotstein, A. Kapus, and K. Szaszi GEF-H1 Mediates Tumor Necrosis Factor-{alpha}-induced Rho Activation and Myosin Phosphorylation: ROLE IN THE REGULATION OF TUBULAR PARACELLULAR PERMEABILITY J. Biol. Chem., April 24, 2009; 284(17): 11454 - 11466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Babbin, S. Koch, M. Bachar, M.-A. Conti, C. A. Parkos, R. S. Adelstein, A. Nusrat, and A. I. Ivanov Non-Muscle Myosin IIA Differentially Regulates Intestinal Epithelial Cell Restitution and Matrix Invasion Am. J. Pathol., February 1, 2009; 174(2): 436 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. K. Hoffmann, I. H. Lambert, and S. F. Pedersen Physiology of Cell Volume Regulation in Vertebrates Physiol Rev, January 1, 2009; 89(1): 193 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C. Stuart, Z. Jia, A. Messenberg, B. Joshi, T. M. Underhill, H. Moukhles, and I. R. Nabi Localized Rho GTPase Activation Regulates RNA Dynamics and Compartmentalization in Tumor Cell Protrusions J. Biol. Chem., December 12, 2008; 283(50): 34785 - 34795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Leve, W. de Souza, and J. A. Morgado-Diaz A Cross-Link between Protein Kinase A and Rho-Family GTPases Signaling Mediates Cell-Cell Adhesion and Actin Cytoskeleton Organization in Epithelial Cancer Cells J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 777 - 788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Vaahtomeri, E. Ventela, K. Laajanen, P. Katajisto, P.-J. Wipff, B. Hinz, T. Vallenius, M. Tiainen, and T. P. Makela Lkb1 is required for TGF{beta}-mediated myofibroblast differentiation J. Cell Sci., November 1, 2008; 121(21): 3531 - 3540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Elberg, L. Chen, D. Elberg, M. D. Chan, C. J. Logan, and M. A. Turman MKL1 mediates TGF-{beta}1-induced {alpha}-smooth muscle actin expression in human renal epithelial cells Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1116 - F1128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Busche, A. Descot, S. Julien, H. Genth, and G. Posern Epithelial cell-cell contacts regulate SRF-mediated transcription via Rac-actin-MAL signalling J. Cell Sci., April 1, 2008; 121(7): 1025 - 1035. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Alcorn, A. S. Guala, J. van der Velden, B. McElhinney, C. G. Irvin, R. J. Davis, and Y. M. W. Janssen-Heininger Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-{beta}1 J. Cell Sci., April 1, 2008; 121(7): 1036 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kisseleva and D. A. Brenner Mechanisms of Fibrogenesis Experimental Biology and Medicine, February 1, 2008; 233(2): 109 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Morita, T. Mayanagi, and K. Sobue Dual roles of myocardin-related transcription factors in epithelial mesenchymal transition via slug induction and actin remodeling J. Cell Biol., December 3, 2007; 179(5): 1027 - 1042. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
